Management of Brain Arteriovenous Malformations

被引:9
|
作者
Braksick, Sherri A. [1 ]
Fugate, Jennifer E. [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
Arteriovenous malformation; AVM; ARUBA trial; Endovascular embolization; Cerebral angiography; Embolysates; Stereotactic radiosurgery; Microsurgery; Combination therapy; INTRACRANIAL VASCULAR MALFORMATIONS; GAMMA-KNIFE RADIOSURGERY; N-BUTYL CYANOACRYLATE; STEREOTACTIC RADIOSURGERY; NATURAL-HISTORY; CONSERVATIVE MANAGEMENT; OBLITERATION RATE; EMBOLIZATION; HEMORRHAGE; RISK;
D O I
10.1007/s11940-015-0358-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Arteriovenous malformations (AVMs) pose a risk of morbidity and mortality throughout an affected patient's lifetime. Over the course of a patient's life, the risk of hemorrhage is approximately 1-4 % per year, and after an initial hemorrhage occurs, this risk may be higher. Other causes of morbidity include seizures, headaches, or progressive neurologic deficits. Once an AVM has been discovered, the utility of attempted obliteration or surgical resection compared to the risk of intervention should be entertained. The characteristics of the malformation as well as the patient's overall health status contribute to the decision to intervene on these lesions. For small lesions located in superficial areas without high-risk surgical characteristics (low-grade Spetzler-Martin grades), it is reasonable to consider surgical resection. In lesions that pose high-risk of complications from surgical removal, intra-arterial embolization, radiosurgery, or a combination of the two may be reasonable treatment options. Some AVMs at traditional high surgical risk may be amenable to partial embolization, allowing initially high-risk lesions to become better candidates for surgical resection. In some patients, particularly those who are older or who have multiple medical comorbidities, the risk of intervention as compared to the annual hemorrhage risk may warrant conservative management as opposed to intervention. The overall treatment strategy must be based on patient and AVM characteristics and careful risk-benefit ratio analysis.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Management of Brain Arteriovenous Malformations
    Sherri A. Braksick
    Jennifer E. Fugate
    Current Treatment Options in Neurology, 2015, 17
  • [2] Management of brain arteriovenous malformations
    Lee, Chanhung Z.
    Young, William L.
    CURRENT OPINION IN ANESTHESIOLOGY, 2005, 18 (05) : 484 - 489
  • [3] Management of brain arteriovenous malformations
    Gross, Bradley A.
    Scott, R. M.
    Smith, Edward R.
    LANCET, 2014, 383 (9929): : 1635 - 1635
  • [4] Options for the management of brain arteriovenous malformations
    Harrichandparsad, Rohen
    Royston, D. D.
    Nadvi, S. S.
    NEUROLOGY INDIA, 2017, 65 (06) : 1355 - 1357
  • [5] Acute Management of Brain Arteriovenous Malformations
    Andreas Hartmann
    J. P. Mohr
    Current Treatment Options in Neurology, 2015, 17
  • [6] Recomendation for the management of the brain arteriovenous malformations
    Spagnuolo, E.
    Lemme-Plaghos, L.
    Revilla, F.
    Quintana, L.
    Antico, J.
    NEUROCIRUGIA, 2009, 20 (01): : 5 - 14
  • [7] Management of Ruptured Brain Arteriovenous Malformations
    Brad E. Zacharia
    Kerry A. Vaughan
    Adam Jacoby
    Zachary L. Hickman
    Daniel Bodmer
    E. Sander Connolly
    Current Atherosclerosis Reports, 2012, 14 : 335 - 342
  • [8] Management of unruptured brain arteriovenous malformations
    Knopman, Jared
    Stieg, Philip E.
    LANCET, 2014, 383 (9917): : 581 - 583
  • [9] Endovascular Management of Brain Arteriovenous Malformations
    Ognard, Julien
    Magro, Elsa
    Caroff, Jildaz
    Bodani, Vivek
    Mosimann, Pascal John
    Gentric, Jean-Christophe
    SEMINARS IN NEUROLOGY, 2023, 43 (03) : 323 - 336
  • [10] Management of patients with brain arteriovenous malformations
    Söderman, M
    Andersson, T
    Karlsson, B
    Wallace, MC
    Edner, G
    EUROPEAN JOURNAL OF RADIOLOGY, 2003, 46 (03) : 195 - 205